Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension

This is a multicenter, open-label study to evaluate the dose of Orenitram® (treprostinil) Extended Release Tablets achieved at 16 weeks after a short-term course of Remodulin® (treprostinil

hysterectomy
connective tissue disease
left ventricular end-diastolic pressure
hypertrophy
hypertension
  • 97 views
  • 23 Mar, 2022
  • 2 locations
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

This pilot study aims to assess the safety and treatment effect of acute dosing with IV Remodulin in neonates with persistent pulmonary hypertension of the newborn (PPHN).

  • 43 views
  • 06 May, 2022
  • 15 locations